Abs 0135 suggests that JAKi may successful tx for Inflammatory ocular pathology (IOP), including uveitis, epi/scleritis, & peripheral ulcerative keratitis, including after failure of cs/bDMARDs. #ACR22 @RheumNow https://t.co/9EDhtSzj1C https://t.co/0LqssF1P8H
Links:
Janus Kinase Inhibitors in Severe and Refractory Inflammatory Ocular Pathology…
http://ow.ly/tLVf50LtLvg
12-11-2022
